Ftse Mib
33.806,95
-1,73%
DAX
19.969,86
-1,44%
S&P 500
5.901,86
0,51%
NASDAQ
19.556,64
0,85%
Bitcoin
100.293,99
0,23%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Wave Life Sciences Ltd (WVE) Wave Life Sciences Ltd (WVE) Notizie

Wave Life Sciences Ltd

WVE
12,99
-0,10 (-0,76%)
Ultimo aggiornamento: 17:56:22
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/12/202414:30GLOBEWave Life Sciences to Present at 43rd Annual J.P. Morgan..
28/11/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202414:30GLOBEWave Life Sciences to Present at Upcoming Investor..
25/11/202423:09EDGAR2Form 144 - Report of proposed sale of securities
20/11/202412:05EDGAR2Form 8-K - Current report
16/11/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202422:16EDGAR2Form 144 - Report of proposed sale of securities
15/11/202414:30GLOBEWave Life Sciences to Present at Jefferies London Healthcare..
14/11/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202422:30EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202414:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/11/202413:58EDGAR2Form S-3ASR - Automatic shelf registration statement of..
12/11/202413:30GLOBEWave Life Sciences Reports Third Quarter 2024 Financial..
08/11/202422:14EDGAR2Form 144 - Report of proposed sale of securities
08/11/202420:17EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
04/11/202422:05GLOBEWave Life Sciences Third Quarter 2024 Financial Results..
30/10/202422:13EDGAR2Form 8-K - Current report
30/10/202421:45GLOBEWave Life Sciences Highlights Growing Pipeline at Research..
19/10/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202422:19EDGAR2Form 144 - Report of proposed sale of securities
16/10/202422:13EDGAR2Form 144 - Report of proposed sale of securities
16/10/202414:34EDGAR2Form 8-K - Current report
16/10/202414:30GLOBEWave Life Sciences Announces First-Ever Therapeutic RNA..
16/10/202414:25GLOBEWave Life Sciences Announces Upcoming Virtual Research Day..
15/10/202423:15EDGAR2Form 8-K - Current report
12/10/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202415:20GLOBEWave Life Sciences Announces Closing of Upsized Public..
01/10/202413:35EDGAR2Form 8-K - Current report
30/9/202414:30GLOBEWave Life Sciences to Present at Chardan 8th Annual Genetic..
28/9/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202412:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/9/202423:18EDGAR2Form 8-K - Current report
26/9/202403:40EDGAR2Form 144 - Report of proposed sale of securities
26/9/202403:14GLOBEWave Life Sciences Prices Upsized $200 Million Public..
24/9/202423:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
24/9/202423:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
24/9/202422:01GLOBEWave Life Sciences Announces Proposed Public Offering of..
24/9/202413:34EDGAR2Form 8-K - Current report
24/9/202413:30GLOBEWave Life Sciences Announces Positive Interim Data from..
24/8/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202422:24EDGAR2Form 144 - Report of proposed sale of securities
15/8/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202423:29EDGAR2Form 8-K - Current report
12/8/202414:30GLOBEWave Life Sciences Receives FDA Rare Pediatric Disease..
08/8/202413:55EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:37EDGAR2Form 8-K - Current report
08/8/202413:30GLOBEWave Life Sciences Reports Second Quarter 2024 Financial..
Apertura: 13,08 Min: 12,98 Max: 13,55
Chiusura: 13,09

La tua Cronologia

NASDAQ
WVE
Wave Life Sciences
BIT
P18XG4
BNP Paribas Issuance
BIT
F39147
Vontobel Financial Produ...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network